Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,297 | 160 | 98.0% |
| Education | $46.24 | 1 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $507.86 | 21 | $0 (2024) |
| PFIZER INC. | $254.02 | 17 | $0 (2024) |
| Lilly USA, LLC | $248.85 | 28 | $0 (2024) |
| ABBVIE INC. | $227.43 | 19 | $0 (2024) |
| Novo Nordisk Inc | $219.66 | 15 | $0 (2024) |
| Amgen Inc. | $167.15 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $95.58 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $84.07 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $81.71 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $58.21 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,940 | 134 | AstraZeneca Pharmaceuticals LP ($479.57) |
| 2023 | $402.47 | 27 | ABBVIE INC. ($45.83) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Bone Health | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.27 | General |
| 12/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Biological | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.17 | General |
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.93 | General |
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.93 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.42 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $46.24 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.45 | General |
| 10/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Cardio-renal | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 337 | 396 | $49,480 | $17,593 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 109 | $20,492 | $7,230 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 79 | $21,172 | $7,137 | 33.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 26 | 26 | $2,028 | $1,307 | 64.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 25 | 26 | $2,236 | $641.42 | 28.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 38 | 42 | $420.00 | $344.40 | 82.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 26 | 28 | $812.00 | $289.80 | 35.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 35 | 38 | $798.00 | $281.57 | 35.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 12 | 12 | $444.00 | $157.44 | 35.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 13 | $871.00 | $135.33 | 15.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 21 | 23 | $207.00 | $68.42 | 33.1% |
About Dr. Austin Granatowicz, MD
Dr. Austin Granatowicz, MD is a Family Medicine healthcare provider based in South Sioux City, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2020. The National Provider Identifier (NPI) number assigned to this provider is 1184240533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Austin Granatowicz, MD has received a total of $2,343 in payments from pharmaceutical and medical device companies, with $1,940 received in 2024. These payments were reported across 161 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,297).
As a Medicare-enrolled provider, Granatowicz has provided services to 337 Medicare beneficiaries, totaling 396 services with total Medicare billing of $17,593. Data is available for 1 year (2023–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location South Sioux City, NE
- Active Since 06/22/2020
- Last Updated 12/05/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1184240533
Products in Payments
- FARXIGA (Drug) $274.12
- MOUNJARO (Drug) $146.78
- ELIQUIS (Drug) $142.46
- VRAYLAR (Drug) $142.31
- Otezla (Drug) $100.10
- Ozempic (Drug) $98.01
- NURTEC ODT (Drug) $96.39
- TRADJENTA (Drug) $95.58
- Rybelsus (Drug) $90.48
- JARDIANCE (Drug) $89.84
- LEQVIO (Drug) $84.07
- EVENITY (Biological) $67.05
- Veozah (Drug) $58.21
- Kerendia (Drug) $56.41
- Tymlos (Drug) $55.29
- GARDASIL (Biological) $49.41
- BREZTRI (Drug) $46.24
- YUPELRI (Drug) $44.11
- UBRELVY (Drug) $39.63
- Crysvita (Drug) $34.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Sioux City
Dr. Michael Brenner, M.d, M.D
Family Medicine — Payments: $17,646
Michael Hattan, Md, MD
Family Medicine — Payments: $11,240
Thomas Wente, Do, DO
Family Medicine — Payments: $10,128
Melissa Austreim-Krell, M.d, M.D
Family Medicine — Payments: $8,652
David Ensz, M.d, M.D
Family Medicine — Payments: $7,676
Suhair Najdawi, Md, MD
Family Medicine — Payments: $4,040